Healthcare - Biotechnology - NASDAQ - US
$ 22.48
-9.79 %
$ 1.54 B
Market Cap
-4.69
P/E
Price Target
Average
192.85%
Revenue Forecast
Estimate
66.52%
EBIT
Estimate
--10.73%
Net Income
Estimate
38.94%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arvinas, Inc.
Wall Street analysts predict an average 1-year price target for ARVN of $65.8 , with forecasts ranging from a low of $40 to a high of $87 .
ARVN Lowest Price Target
Wall Street Target
40 USD
77.94%
ARVN Average Price Target
Wall Street Target
65.8 USD
192.85%
ARVN Highest Price Target
Wall Street Target
87 USD
287.01%
REVENUE FORECAST
Revenue Forecast Chart ARVN
EBIT FORECAST
EBIT Forecast Chart ARVN
NET INCOME FORECAST
Net Income Chart ARVN